Recurrent Ovarian Endometrioid Adenocarcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11105 | Benzalkonium | 1 | Recruiting | 1 |
DB00997 | Doxorubicin | 1 | Recruiting | 1 |
DB16252 | Nedisertib | 1 | Recruiting | 1 |
DB00759 | Tetracycline | 1 | Recruiting | 1 |
DB00158 | Folic acid | 1 / 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB04849 | Cediranib | 2 | Active Not Recruiting | 1 |
DB12483 | Copanlisib | 2 | Withdrawn | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Withdrawn | 1 |
DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 2 |
DB09074 | Olaparib | 2 | Withdrawn | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Withdrawn | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB12887 | Tazemetostat | 2 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 | Withdrawn | 1 |
DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |
DB01030 | Topotecan | 2 | Withdrawn | 1 |
DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 / 3 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 3 | Active Not Recruiting | 1 |
DB04849 | Cediranib | 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 3 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 3 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 3 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 3 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 3 | Active Not Recruiting | 1 |